Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03109210 · ClinicalTrials.gov registry record · NA

Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea

A NA study of Sleep Apnea, Obstructive and Insomnia, Primary, sponsored by National Jewish Health.

Active
Registry status
NA
Development phase
384
Enrollment target
2
Study locations

NCT03109210: Active NA study of Sleep Apnea, Obstructive and Insomnia, Primary, sponsored by National Jewish Health.

NCT03109210 is a NA study of Sleep Apnea, Obstructive and Insomnia, Primary that is active but no longer recruiting, run by National Jewish Health. The registered enrollment target is 384 participants, above the 254-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (51% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03109210, a NA study of Sleep Apnea, Obstructive and Insomnia, Primary, is active but no longer recruiting, sponsored by National Jewish Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
384 participants
Enrollment target
2
Study locations

Study Summary

This two-site randomized clinical trial will investigate and compare three treatments for insomnia in patients who have been diagnosed with and treated for sleep apnea: online cognitive behavioral therapy (OCBT), therapist-directed cognitive behavioral therapy (TCBT), and standard clinical care. 384 patients will be recruited and will attend up to 15 visits over 10 months. Visits will include baseline assessment, treatment visits, and post-treatment follow-up visits. Visits will involve completion of questionnaires, meeting with therapists, and a physical exam.

Primary Outcome

Change in participants' score on the ISI will be measured over baseline, post-treatment, and follow-up visits.

Interventions

  • BEHAVIORAL Online Cognitive Behavioral Therapy (OCBT)
  • BEHAVIORAL Therapist-directed Cognitive Behavioral Therapy (TCBT)

Study Locations (2)

California

  • Stanford Univeristy - Palo Alto

Colorado

  • National Jewish Health - Denver

Trial Details

FieldValue
Enrollment Target 384 participants
Start Date 2017-04-15
Est. Completion 2026-06-30
Phase NA
National Jewish Health

83 total trials

What the registry record for NCT03109210 still lists

NCT03109210 is an interventional study that assigns participants to a tested intervention. The registered 384 participants enrollment target is mid-sized for trials with a published cap, above the 254-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (51% higher).

The record links to 2 conditions, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 2 interventions - of which Online Cognitive Behavioral Therapy (OCBT) is the first listed.

NCT03109210 reports a single indexed study location in California, Colorado.

Frequently Asked Questions

What is clinical trial NCT03109210 about?

NCT03109210 is a clinical study titled "Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea". This two-site randomized clinical trial will investigate and compare three treatments for insomnia in patients who have been diagnosed with and treated for sleep apnea: online cognitive behavioral therapy (OCBT), therapist-directed cognitive behavioral therapy (TCBT), and standard clinical care. 384...

What is the current status of trial NCT03109210?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 384 participants. The study started on 2017-04-15. Estimated completion is 2026-06-30.

What conditions does trial NCT03109210 study?

This clinical trial studies the following conditions: Sleep Apnea, Obstructive, Insomnia, Primary.

What interventions are being tested in trial NCT03109210?

The interventions under investigation include: Online Cognitive Behavioral Therapy (OCBT) (BEHAVIORAL), Therapist-directed Cognitive Behavioral Therapy (TCBT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03109210?

This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03109210 being conducted?

This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea, Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03109210's enrollment target sits among peer trials

384 7th of 45 higher than 39 of 45 other Sleep Apnea, Obstructive trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06277661 · 384 participants · NA

    The Mom and Infant Outcomes (MOMI) Study

  • NCT06372964 · 384 participants · Phase 3

    Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  • NCT06501040 · 384 participants · NA

    Increasing Knowledge and Interest in Cancer Clinical Trials

  • NCT06566703 · 384 participants · NA

    Testing ANSOS for Efficacy in Multi-Tribal Urban Communities

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03109210, the US trial registry maintained by the National Library of Medicine. NCT03109210 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.